John Peterson

Stock Analyst at Piper Sandler

(0.04)
# 4,360
Out of 4,820 analysts
5
Total ratings
n/a
Success rate
n/a
Average return
Main Sectors:
Top Industries:

Stocks Rated by John Peterson

Myriad Genetics
Jan 30, 2025
Maintains: Neutral
Price Target: $24$14
Current: $7.42
Upside: +88.68%